Novo Nordisk A/S (NVO) Free Cash Flow Yield: 2.50%
Is Novo Nordisk A/S’s free cash flow yield high or low?
Novo Nordisk A/S's free cash flow yield of 2.50% is 12% below its 5-year average of 2.85%, around the middle of its 5-year range (1.09%–5.21%).
As of Wednesday, June 17, 2026. 26.47% below its 12-month average of 3.40%.
NVO Free Cash Flow Yield Chart
NVO Average Free Cash Flow Yield Chart
NVO Current vs Average Free Cash Flow Yield Chart
NVO Free Cash Flow Yield Metrics
FREE CASH FLOW YIELD
2.50%
FREE CASH FLOW YIELD AVG TTM
3.40%
FREE CASH FLOW YIELD AVG 3Y
2.63%
FREE CASH FLOW YIELD AVG 5Y
2.84%
FREE CASH FLOW YIELD AVG 10Y
3.60%
FREE CASH FLOW YIELD AVG 15Y
3.66%
FREE CASH FLOW YIELD AVG 20Y
3.81%
CURRENT VS TTM AVG
-26.47%
CURRENT VS 3Y AVG
-4.81%
CURRENT VS 5Y AVG
-12.05%
CURRENT VS 10Y AVG
-30.55%
CURRENT VS 15Y AVG
-31.68%
CURRENT VS 20Y AVG
-34.32%
NVO Competitors' Free Cash Flow Yield
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $193.39B | 2.50% | 3.40% | 2.63% | 2.84% |
| Amgen Inc. (AMGN)vs › | $184.40B | 4.63% | 5.85% | 5.47% | 5.87% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $171.57B | 3.92% | 3.34% | 3.40% | 3.32% |
| Gilead Sciences, Inc. (GILD)vs › | $155.75B | 6.50% | 6.07% | 7.44% | 8.68% |
| Abbott Laboratories (ABT)vs › | $154.08B | 4.77% | 3.51% | 3.07% | 3.51% |
| Pfizer Inc. (PFE)vs › | $147.73B | 6.39% | 7.32% | 5.91% | 7.34% |
| Intuitive Surgical, Inc. (ISRG)vs › | $142.44B | 1.96% | 1.30% | 0.87% | 1.09% |
| Danaher Corporation (DHR)vs › | $128.06B | 4.10% | 3.50% | 3.47% | 3.67% |
| CVS Health Corporation (CVS)vs › | $127.73B | 5.74% | 6.51% | 9.17% | 10.64% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $116.49B | 3.15% | 3.06% | 3.41% | 3.83% |
Yield Comparison
FCF Yield
2.50%
Earnings Yield
9.82%
Dividend Yield
4.14%
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
- Shows free cash flow after capital expenditures relative to market cap
- Can be compared with earnings yield and dividend yield
- Can be compared with the company's historical range
- Can be compared with peers that report positive free cash flow
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
Novo Nordisk A/S Free Cash Flow Yield Formula & Definition
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Novo Nordisk A/S Free Cash Flow Yield FAQ
- What is the free cash flow yield for Novo Nordisk A/S (NVO)?
- The free cash flow yield for NVO stock is 2.50%.
- Is Novo Nordisk A/S's free cash flow yield high or low?
- Novo Nordisk A/S's free cash flow yield of 2.50% is 12% below its 5-year average of 2.85%, around the middle of its 5-year range (1.09%–5.21%).
- What is the TTM average free cash flow yield for Novo Nordisk A/S (NVO)?
- The TTM average free cash flow yield for NVO stock is 3.40%.
- What is the 3Y average free cash flow yield for Novo Nordisk A/S (NVO)?
- The 3Y average free cash flow yield for NVO stock is 2.63%.
- What is the 5Y average free cash flow yield for Novo Nordisk A/S (NVO)?
- The 5Y average free cash flow yield for NVO stock is 2.84%.
- What is the 10Y average free cash flow yield for Novo Nordisk A/S (NVO)?
- The 10Y average free cash flow yield for NVO stock is 3.60%.
- What is the 15Y average free cash flow yield for Novo Nordisk A/S (NVO)?
- The 15Y average free cash flow yield for NVO stock is 3.66%.
- What is the 20Y average free cash flow yield for Novo Nordisk A/S (NVO)?
- The 20Y average free cash flow yield for NVO stock is 3.81%.
Novo Nordisk A/S Free Cash Flow Yield History
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-06-17 | 2.50% |
| 2026-06-16 | 2.50% |
| 2026-06-15 | 2.48% |
| 2026-06-12 | 2.48% |
| 2026-06-11 | 2.48% |
| 2026-06-10 | 2.55% |
| 2026-06-09 | 2.58% |
| 2026-06-08 | 2.66% |
| 2026-06-05 | 2.54% |
| 2026-06-04 | 2.49% |
| 2026-06-03 | 2.59% |
| 2026-06-02 | 2.54% |
| 2026-06-01 | 2.47% |
| 2026-05-29 | 2.39% |
| 2026-05-28 | 2.39% |
| 2026-05-27 | 2.45% |
| 2026-05-26 | 2.47% |
| 2026-05-22 | 2.42% |
| 2026-05-21 | 2.46% |
| 2026-05-20 | 2.42% |
| 2026-05-19 | 2.46% |
| 2026-05-18 | 2.46% |
| 2026-05-15 | 2.44% |
| 2026-05-14 | 2.38% |
| 2026-05-13 | 2.31% |
| 2026-05-12 | 2.32% |
| 2026-05-11 | 2.35% |
| 2026-05-08 | 2.37% |
| 2026-05-07 | 2.38% |
| 2026-05-06 | 2.38% |
| 2026-05-05 | 2.23% |
| 2026-05-04 | 2.25% |
| 2026-05-01 | 2.28% |
| 2026-04-30 | 2.36% |
| 2026-04-29 | 2.48% |
| 2026-04-28 | 2.42% |
| 2026-04-27 | 2.42% |
| 2026-04-24 | 2.42% |
| 2026-04-23 | 2.59% |
| 2026-04-22 | 2.55% |
| 2026-04-21 | 2.53% |
| 2026-04-20 | 2.47% |
| 2026-04-17 | 2.46% |
| 2026-04-16 | 2.44% |
| 2026-04-15 | 2.45% |
| 2026-04-14 | 2.54% |
| 2026-04-13 | 2.63% |
| 2026-04-10 | 2.66% |
| 2026-04-09 | 2.67% |
| 2026-04-08 | 2.65% |
| 2026-04-07 | 2.70% |
| 2026-04-06 | 2.72% |
| 2026-04-02 | 2.70% |
| 2026-04-01 | 2.74% |
| 2026-03-31 | 2.72% |
| 2026-03-30 | 2.83% |
| 2026-03-27 | 2.77% |
| 2026-03-26 | 2.74% |
| 2026-03-25 | 2.75% |
| 2026-03-24 | 2.71% |
| 2026-03-23 | 2.71% |
| 2026-03-20 | 2.73% |
| 2026-03-19 | 2.69% |
| 2026-03-18 | 2.67% |
| 2026-03-17 | 2.60% |
| 2026-03-16 | 2.59% |
| 2026-03-13 | 2.63% |
| 2026-03-12 | 2.63% |
| 2026-03-11 | 2.57% |
| 2026-03-10 | 2.58% |
| 2026-03-09 | 2.51% |
| 2026-03-06 | 2.59% |
| 2026-03-05 | 2.56% |
| 2026-03-04 | 2.59% |
| 2026-03-03 | 2.72% |
| 2026-03-02 | 2.64% |
| 2026-02-27 | 2.67% |
| 2026-02-26 | 2.65% |
| 2026-02-25 | 2.62% |
| 2026-02-24 | 2.59% |
| 2026-02-23 | 2.52% |
| 2026-02-20 | 2.11% |
| 2026-02-19 | 2.06% |
| 2026-02-18 | 2.03% |
| 2026-02-17 | 2.02% |
| 2026-02-13 | 2.01% |
| 2026-02-12 | 2.04% |
| 2026-02-11 | 2.05% |
| 2026-02-10 | 2.03% |
| 2026-02-09 | 2.02% |
| 2026-02-06 | 2.10% |
| 2026-02-05 | 2.30% |
| 2026-02-04 | 2.12% |
| 2026-02-03 | 1.98% |
| 2026-02-02 | 3.64% |
| 2026-01-30 | 3.61% |
| 2026-01-29 | 3.61% |
| 2026-01-28 | 3.55% |
| 2026-01-27 | 3.41% |
| 2026-01-26 | 3.35% |
| 2026-01-23 | 3.44% |
| 2026-01-22 | 3.45% |
| 2026-01-21 | 3.61% |
| 2026-01-20 | 3.53% |
| 2026-01-16 | 3.44% |
| 2026-01-15 | 3.75% |
| 2026-01-14 | 3.64% |
| 2026-01-13 | 3.59% |
| 2026-01-12 | 3.58% |
| 2026-01-09 | 3.65% |
| 2026-01-08 | 3.74% |
| 2026-01-07 | 3.79% |
| 2026-01-06 | 3.81% |
| 2026-01-05 | 3.89% |
| 2026-01-02 | 4.09% |
| 2025-12-31 | 4.21% |
| 2025-12-30 | 4.19% |
| 2025-12-29 | 4.16% |
| 2025-12-26 | 4.09% |
| 2025-12-24 | 4.08% |
| 2025-12-23 | 4.15% |
| 2025-12-22 | 4.46% |
| 2025-12-19 | 4.46% |
| 2025-12-18 | 4.50% |
| 2025-12-17 | 4.49% |
| 2025-12-16 | 4.38% |
| 2025-12-15 | 4.26% |
| 2025-12-12 | 4.27% |
| 2025-12-11 | 4.26% |
| 2025-12-10 | 4.37% |
| 2025-12-09 | 4.63% |
| 2025-12-08 | 4.59% |
| 2025-12-05 | 4.48% |
| 2025-12-04 | 4.47% |
| 2025-12-03 | 4.51% |
| 2025-12-02 | 4.52% |
| 2025-12-01 | 4.43% |
| 2025-11-28 | 4.34% |
| 2025-11-26 | 4.40% |
| 2025-11-25 | 4.56% |
| 2025-11-24 | 4.77% |
| 2025-11-21 | 4.50% |
| 2025-11-20 | 4.50% |
| 2025-11-19 | 4.38% |
| 2025-11-18 | 4.51% |
| 2025-11-17 | 4.42% |
| 2025-11-14 | 4.44% |
| 2025-11-13 | 4.36% |
| 2025-11-12 | 4.27% |
| 2025-11-11 | 4.36% |
| 2025-11-10 | 4.67% |
| 2025-11-07 | 4.69% |
| 2025-11-06 | 4.61% |
| 2025-11-05 | 4.42% |
| 2025-11-04 | 4.38% |
| 2025-11-03 | 4.30% |
| 2025-10-31 | 4.27% |
| 2025-10-30 | 4.22% |
| 2025-10-29 | 4.12% |
| 2025-10-28 | 4.06% |
| 2025-10-27 | 4.00% |
| 2025-10-24 | 3.99% |
| 2025-10-23 | 3.97% |
| 2025-10-22 | 3.96% |
| 2025-10-21 | 3.86% |
| 2025-10-20 | 3.79% |
| 2025-10-17 | 3.89% |
| 2025-10-16 | 3.77% |
| 2025-10-15 | 3.73% |
| 2025-10-14 | 3.73% |
| 2025-10-13 | 3.68% |
| 2025-10-10 | 3.71% |
| 2025-10-09 | 3.60% |
| 2025-10-08 | 3.55% |
| 2025-10-07 | 3.58% |
| 2025-10-06 | 3.54% |
| 2025-10-03 | 3.54% |
| 2025-10-02 | 3.60% |
| 2025-10-01 | 3.57% |
| 2025-09-30 | 3.81% |
| 2025-09-29 | 3.81% |
| 2025-09-26 | 3.80% |
| 2025-09-25 | 3.77% |
| 2025-09-24 | 3.60% |
| 2025-09-23 | 3.55% |
| 2025-09-22 | 3.48% |
| 2025-09-19 | 3.44% |
| 2025-09-18 | 3.42% |
| 2025-09-17 | 3.63% |
| 2025-09-16 | 3.70% |
| 2025-09-15 | 3.80% |
| 2025-09-12 | 3.85% |
| 2025-09-11 | 3.89% |
| 2025-09-10 | 3.89% |
| 2025-09-09 | 3.89% |
| 2025-09-08 | 3.89% |
| 2025-09-05 | 3.83% |
| 2025-09-04 | 3.77% |
| 2025-09-03 | 3.73% |
| 2025-09-02 | 3.75% |
| 2025-08-29 | 3.74% |
| 2025-08-28 | 3.77% |
| 2025-08-27 | 3.75% |
| 2025-08-26 | 3.82% |
| 2025-08-25 | 3.75% |
| 2025-08-22 | 3.71% |
| 2025-08-21 | 3.81% |
| 2025-08-20 | 3.89% |
| 2025-08-19 | 3.86% |
| 2025-08-18 | 3.93% |
| 2025-08-15 | 4.03% |
| 2025-08-14 | 4.15% |
| 2025-08-13 | 4.15% |
| 2025-08-12 | 4.25% |
| 2025-08-11 | 4.24% |
| 2025-08-08 | 4.14% |
| 2025-08-07 | 4.33% |
| 2025-08-06 | 4.66% |
| 2025-08-05 | 5.19% |
| 2025-08-04 | 5.03% |
| 2025-08-01 | 5.09% |
| 2025-07-31 | 5.21% |
| 2025-07-30 | 4.90% |
| 2025-07-29 | 4.55% |
| 2025-07-28 | 3.55% |
| 2025-07-25 | 3.42% |
| 2025-07-24 | 3.47% |
| 2025-07-23 | 3.50% |
| 2025-07-22 | 3.67% |
| 2025-07-21 | 3.78% |
| 2025-07-18 | 3.81% |
| 2025-07-17 | 3.76% |
| 2025-07-16 | 3.66% |
| 2025-07-15 | 3.65% |
| 2025-07-14 | 3.56% |
| 2025-07-11 | 3.56% |
| 2025-07-10 | 3.45% |
| 2025-07-09 | 3.52% |
| 2025-07-08 | 3.52% |
| 2025-07-07 | 3.54% |
| 2025-07-03 | 3.54% |
| 2025-07-02 | 3.51% |
| 2025-07-01 | 3.51% |
| 2025-06-30 | 3.55% |
| 2025-06-27 | 3.58% |
| 2025-06-26 | 3.62% |
| 2025-06-25 | 3.64% |
| 2025-06-24 | 3.47% |
| 2025-06-23 | 3.52% |
| 2025-06-20 | 3.32% |
| 2025-06-18 | 3.31% |
| 2025-06-17 | 3.30% |
| 2025-06-16 | 3.18% |
| 2025-06-13 | 3.07% |
| 2025-06-12 | 3.03% |
| 2025-06-11 | 3.12% |
| 2025-06-10 | 3.09% |
| 2025-06-09 | 3.25% |
| 2025-06-06 | 3.29% |
| 2025-06-05 | 3.38% |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar